A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Children's Cancer Group, China
Dana-Farber Cancer Institute
Children's Oncology Group
St. Jude Children's Research Hospital
City of Hope Medical Center
Second Affiliated Hospital of Soochow University
Medical College of Wisconsin
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
Radiation Therapy Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Alliance for Clinical Trials in Oncology
St. Jude Children's Research Hospital
BTG International Inc.
Gustave Roussy, Cancer Campus, Grand Paris
South Plains Oncology Consortium
Milton S. Hershey Medical Center
National Institute of Allergy and Infectious Diseases (NIAID)
SWOG Cancer Research Network
National Institute of Allergy and Infectious Diseases (NIAID)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Takeda
UNICANCER
M.D. Anderson Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Northwestern University
M.D. Anderson Cancer Center
Children's Oncology Group
Children's Hospital of Philadelphia
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
AIDS Malignancy Consortium
Radiation Therapy Oncology Group
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute